Transderm® Infusion distribution
DEP Medical distributes Transderm® Infusion exclusively in North America.
Source: LinkedIn company description · Retrieved October 13, 2026
DEP Medical is the exclusive North American distributor of Transderm® Infusion.
The DermoElectroPoration® System is described as a Class II FDA-cleared biophysical alternative for infusing high-weight molecule modalities into the dermis without needles. The DEP System is a non-invasive, standalone powered drug-delivery system.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The DermoElectroPoration® System is presented for medical professionals.
DEP Medical distributes Transderm® Infusion exclusively in North America.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026 and September 21, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.